Koers Haemonetics Corporation
Aandelen
HAE
US4050241003
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
86,22 USD | +1,35% | +1,58% | +0,83% |
Omzet 2024 * | 1,3 mld. 1,21 mld. | Omzet 2025 * | 1,37 mld. 1,28 mld. | Marktkapitalisatie | 4,38 mld. 4,08 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 126 mln. 117 mln. | Nettowinst (verlies) 2025 * | 158 mln. 147 mln. | EV/omzet 2024 * | 3,84 x |
Nettoschuld 2024 * | 595 mln. 555 mln. | Nettoschuld 2025 * | 508 mln. 474 mln. | EV/omzet 2025 * | 3,56 x |
K/w-verhouding 2024 * |
34,6
x | K/w-verhouding 2025 * |
26,4
x | Werknemers | 3.034 |
Dividendrendement 2024 * |
2,32% | Dividendrendement 2025 * |
2,32% | Vrij verhandelbaar | 99,24% |
Recentste transcriptie over Haemonetics Corporation
1 dag | +1,35% | ||
1 week | +1,58% | ||
Lopende maand | +1,02% | ||
1 maand | +7,40% | ||
3 maanden | +5,43% | ||
6 maanden | -1,83% | ||
Lopend jaar | +0,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 60 | 16-05-16 | |
James D'Arecca
DFI | Director of Finance/CFO | 53 | 11-04-22 |
Jan Hartmann
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Abernathy
BRD | Director/Board Member | 69 | 18-10-17 |
Director/Board Member | 69 | 23-07-14 | |
Ellen Zane
CHM | Chairman | 72 | 25-01-18 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.28% | 45 M€ | +0,35% | ||
0.14% | 509 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 86,22 | +1,35% | 238 823 |
23-04-24 | 85,07 | +1,73% | 231 275 |
22-04-24 | 83,62 | +2,93% | 402 130 |
19-04-24 | 81,24 | -2,66% | 845 073 |
18-04-24 | 83,46 | -1,67% | 966 385 |
uitgestelde koers Nyse, 24 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,83% | 4,38 mld. | |
-2,89% | 185 mld. | |
-2,43% | 107 mld. | |
-4,10% | 67,55 mld. | |
+11,10% | 54,6 mld. | |
+15,86% | 47,42 mld. | |
+3,86% | 42,24 mld. | |
+9,55% | 28,24 mld. | |
+1,85% | 26,42 mld. | |
+12,40% | 25,66 mld. |